Planning a Health Canada PRCI Compliant Submission
How to set yourself up for a successful Health Canada PRCI submission
Certara2021 年 4 月 26 日
Part 3: Oligonucleotide therapeutic development: Clinical pharmacology considerations
In the last few years, the pharmaceutical industry has invested in developing Complex Biologics including…
Certara2021 年 4 月 21 日
Part 2: Oligonucleotide therapeutic development: Pre-clinical and translational considerations
In the last few years, the pharmaceutical industry has invested in developing Complex Biologics including…
Certara2021 年 4 月 21 日
Part 1: What are oligonucleotide therapeutics, and how do they work?
In the last few years, the pharmaceutical industry has invested in developing Complex Biologics including…
Certara2021 年 4 月 21 日
Plan to Accelerate Your Time to Drug Submissions
There are common themes driving how quickly you can get from your last database lock…
Certara2021 年 4 月 20 日
A Best Practice Framework for Applying PBPK Modeling to Pediatric Drug Development
Pediatric PBPK models have broad application in the drug development process and are being used…
Certara2021 年 4 月 20 日
Overcome Research Hurdles: Expert Guidance for Complex Generic Drug Development
Do expensive bioequivalence studies stall your generic drug approval? Learn how you can streamline complex…
Certara2021 年 4 月 15 日
Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation in the United States
Authors: Joseph McGuirk, Clint Divine, Seung Hyun Moon, Aastha Chandak, Zhiji Zhang, Genovefa A. Papanicolaou…
Certara2021 年 4 月 8 日
Predicting the Effect of the Dulaglutide-Mediated Gastric Emptying Delay on Drug Exposure
The European Medicines Agency (EMA) recently approved dulaglutide (Trulicity®) at higher doses (3 mg and…
Certara2021 年 4 月 1 日
Legislators: Bring all stakeholders to the table to lower drug costs
BY ROMAN CASCIANO, OPINION CONTRIBUTOR — 03/29/21 05:30 PM EDT No one is happy with the…
Certara2021 年 3 月 30 日
